The Gavi Leap
Transforming the Vaccine Alliance for the future through simplicity, transparency and synergy, paving the way for a ‘Global Health Leap’.
Leaving no one behind with immunisation
Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate more than half the world’s children against some of the world's deadliest diseases.
About us Explore our Progress Report
Latest VaccinesWork features
View moreDrug resistance could be behind twice as many Asian hospital deaths as we thought
The largest study of its kind followed 10,000 patients across 19 Asian countries, and found that resistance accounts for a far greater share of deaths from severe hospital infections than population-level modelling had estimated.
A protective dose of the giggles: the Ugandan comics boosting immunisation
Madrat and Chiko are Ugandan comedians using their platforms – both online and on stage – to persuade parents to vaccinate their children.
Could a blood test tell you how well a vaccine will work for you?
A study of more than 4,000 people found that antibodies left over from ordinary past infections predict how strongly someone responds to COVID-19 vaccination, flagging those who need extra doses.
VaccinesWork is an award-winning digital platform hosted by Gavi, covering news, features and explainers from every corner of global health and immunisation.
The Gavi Leap
The Gavi Leap
The Gavi Leap is the most ambitious reform agenda in global health, offering a blueprint for broader reform of the health and development architecture. Learn more about how Leap principles, such as country ownership, radical simplification and innovation, are already having a tangible impact on how immunisation is delivered in Gavi-supported countries.
Our work
Vaccine portfolio
Gavi supports vaccines against 20 infectious diseases, including Ebola, malaria, mpox and rabies.
Health systems support
Strong health and immunisation systems are vital to deliver vaccines to all the children who need them.
Latest Gavi news releases
View allGavi commits additional funding for Ebola response
Gavi, the Vaccine Alliance will provide US$ 7 million to fund a shipment of 70,000 doses of the Ervebo vaccine to DRC.
Gavi, the Vaccine Alliance welcomes the news that the WHO Technical Advisory Group on candidate vaccine prioritization (TAG-CVP) for Bundibugyo virus disease (BVD) outbreak response recommends that the existing approved Ebola vaccine.
Gavi welcomes United States government commitment to unlock funding for fiscal years 2025 and 2026
Gavi, the Vaccine Alliance welcomes the announcement today by the United States Government that it intends to release US$ 600 million in funding appropriated by Congress for Gavi for fiscal years 2025 and 2026.
The Vaccine Alliance
The Vaccine Alliance
Gavi draws on the skills of a variety of partners, combining the technical expertise of the development community with the business know-how of the private sector.
Gavi 6.0 funding guidelines
Newly released funding guidelines outline the scope of Gavi’s vaccine and cash support for the 2026–2030 strategic period (Gavi 6.0), explain how countries should plan and prioritise their immunisation programmes within this support, clarify the requirements for the Gavi 6.0 country application and describe how to access other forms of assistance such as outbreak and emergency support.
Partner countries
Partner countries
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 1.2 billion children – and prevented more than 20.6 million future deaths, helping to halve child mortality in 78 lower‑income countries.
Our donors
Our donors
As a public-private partnership, Gavi is funded by governments, foundations, institutions, organisations, corporations and private individuals.
